DizzyFIX

Abstract: Benign paroxysmal positional vertigo is one of the most common disorders of the vestibular system. It is characterized by episodes of recurrent vertigo triggered by head movements or position changes associated with nystagmus. There is scientific evidence that in the majority of cases this condition responds well to the particle repositioning maneuver (PRM) correctly performed by the physician. However, the PRM needs to be repeated in approximately 30% of the cases. Although the maneuver is simple, patients often find it difficult to perform correctly as self-treatment, with the result that it fails to bring about an improvement in the symptoms. DizzyFix (Clearwater Clinical Limited, Canada) is the name given to a new dynamic visual device designed to provide a visual representation of the PRM based on the canalith theory. The DizzyFiX consists of a specially curved acrylic tube containing a nontoxic viscous fluid and a bead, the purpose of which is to help the patient and the inexperienced physician to perform the PRM correctly. A randomized clinical trial has shown that it reliably enables the maneuver to be performed correctly, and a study investigating the effectiveness of patient self-treatment of benign paroxysmal positional vertigo with the device in comparison with standard office treatment revealed both techniques to be equally effective. The device has now been approved by the US FDA.

Abstract: Objective1) Develop and test a new dynamic visual device for the treatment of Benign Paroxysmal Positional Vertigo (BPPV) 2) Study the efficacy of self-treatment using the DizzyFIX device compared with standard office treatmentMethodsA prospective cohort design was used to study a newly developed device for the improved performance of particle repositioning maneuver (PRM) From September 2007 to March 2008, patients with active BPPV were seen in 4 different clinical practices (n=40) Patients used the device as their only treatment modality Subjective patient reports of resolution were recorded at one week The Dix-Hallpike maneuver was used to measure objective resolution at one week Patient outcome using the device was compared with retrospective physician guided controls (n=40) using a Chi squared testResultsAll patients reported being able to use and understand the device 100% of patients in the prospective cohort reported either a cure or some improvement At one week, 90% of these patients had

Abstract: Objective: The treatment of benign paroxysmal positional vertigo (BPPV) is a repositioning maneuver in order to remove otolithic debris. We use a new device (the DizzyFIX) to assist in the performance of the modified Epley maneuver (MEM). The purpose of this study is to find out the effect of the dizzyFIXR in the treatment of BPPV.Method: Sixty cases of posterior semicircular canal BPPV were studied. All patients were treated by MEM. They were divided into 2 groups. The first group (group A, 30 patients) was only MEM group. The second group (group B, 30 patients) was instructed to use the dizzyFIXR in MEM.Results: In group A and B, dizziness handicap inventory(DHI) scores were found in pre- and post-MEM. (The DHI scores pre- and post-MEM in group A were 40.12 ± 6.58 and 19.42 ± 3.29, p in group A were 6.5 ± 0.5 and 3.4 ± 0.4, and in group B were 6.7 ± 0.4 and 2.2 ± 0.3, P < .05) was noted.Conclusion: From the analysis of this study, the use of this new device to assist in the performance of MEM for the tr...